MedTrace Logo

PK/PD of Single Dose Dapivirine Vaginal Film

NCT01924091 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-09-08

No results posted yet for this study

Summary

To compare drug concentrations in vaginal fluid, genital tissue, and blood

Conditions

  • Pharmaokinetics

Interventions

DRUG

Dapivirine gel

DRUG

Dapivirine film

Sponsors & Collaborators

  • International Partnership for Microbicides, Inc.

    lead INDUSTRY

Principal Investigators

  • Craig Hendrix, MD · John's Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2014-09-30
Completion
2014-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01924091 on ClinicalTrials.gov